Evidence map›Paper›PMID 38612846›Full record

ArticleInternational journal of molecular sciences2024

Effect of Melatonin on Herpesvirus Type 1 Replication.

Zulema Pérez-Martínez, Jose Antonio Boga, Yaiza Potes, Santiago Melón, Ana Coto-Montes

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zulema Pérez-MartínezServicio de Microbiología, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Jose Antonio BogaServicio de Microbiología, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Yaiza PotesInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.ORCID 0000-0002-4687-6230
Santiago MelónServicio de Microbiología, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.ORCID 0000-0001-5770-7902
Ana Coto-MontesInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.ORCID 0000-0002-6609-6258
Hospital Universitario Central de Asturias · ESUniversidad de Oviedo · ES

Funding

Government of the Principado de Asturias IDI/2021/000033Instituto de Salud Carlos III PI21/01596
6 · The paper itself

Abstract

Acute HSV-1 infection is associated with mild symptoms, such as fever and lesions of the mouth, face and skin. This phase is followed by a latency period before reactivation, which is associated with symptoms ranging from ulcers to encephalitis. Despite available anti-HSV-1 drugs, the development of new antiviral agents is sought due to the presence of resistant viruses. Melatonin, a molecule secreted by the pineal gland, has been shown to be an antioxidant, inducer of antioxidant enzymes, and regulator of various biological processes. Clinical trials have explored its therapeutic utility in conditions including infections. This study focuses on melatonin's role in HSV-1 replication and the underlying mechanisms. Melatonin was found to decrease the synthesis of HSV-1 proteins in infected Vero cells measured by immunofluorescence, indicating an inhibition of HSV-1 replication. Additionally, it regulates the activities of antioxidant enzymes and affects proteasome activity. Melatonin activates the unfolded protein response (UPR) and autophagy and suppresses apoptosis in HSV-1-infected cells. In summary, melatonin demonstrates an inhibitory role in HSV-1 replication by modulating various cellular responses, suggesting its potential utility in the treatment of viral infections.

Indexed as

Herpesvirus 1, HumanMelatoninPineal GlandAnimalsAntioxidantsChlorocebus aethiopsVero CellsAntioxidantsMelatoninapoptosisautophagyER stressherpesvirusmelatoninoxidative stress

Identifiers

PMID38612846
PMCPMC11012353
OpenAlexW4393950265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.